Alexza Pharma (ALXA) Tops Q1 EPS by 49c

Alexza Pharma (NASDAQ: ALXA) reported Q1 EPS of ($0.02), $0.49 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $705 thousand versus the consensus estimate of $3.36 million.

For earnings history and earnings-related data on Alexza Pharma (ALXA) click here.

You May Also Be Interested In

• Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
• NextEra Energy (NEE) Tops Q1 EPS by 16c, provides guidance
• Philip Morris International (PM) Tops Q1 EPS by 9c; raises guidance